Management of Persistent Hyperglycemia with Blood Glucose Levels of 400 mg/dL
For a patient with persistent hyperglycemia and blood glucose levels reaching 400 mg/dL, continuous intravenous insulin infusion is the most appropriate initial treatment, followed by transition to a basal-bolus insulin regimen once stabilized.
Initial Assessment and Management
For Blood Glucose ≥400 mg/dL:
- Initiate continuous intravenous (IV) insulin infusion immediately to rapidly correct severe hyperglycemia 1
- Use validated written or computerized protocols that allow for predefined adjustments in the infusion rate based on glucose fluctuations 1
- Monitor glucose levels frequently (≤1 hour intervals) during the period of glycemic instability 1
- Target blood glucose range of 140-180 mg/dL for most patients 1
- Assess for electrolyte abnormalities, particularly potassium, as hypokalaemia is common during treatment of hyperglycemic crises 1
Transition to Subcutaneous Insulin
Once glucose levels stabilize (consecutive readings within target range for 4-6 hours):
Calculate Total Daily Dose (TDD):
Transition Protocol:
Insulin Regimen Structure:
Ongoing Management and Titration
Basal Insulin Adjustment:
- Titrate basal insulin by 2-4 units every 1-3 days until fasting glucose reaches target range 2
- Signs of underbasalization include dose >0.5 units/kg/day or persistently elevated fasting glucose 2
Prandial Insulin Adjustment:
- Start with 4 units or 10% of basal dose before each meal 2
- Titrate by 1-2 units or 10-15% twice weekly based on post-meal glucose readings 2
- Adjust based on carbohydrate content of meals if patient is capable of carbohydrate counting 2
Monitoring Protocol:
- Check glucose before meals and every 4-6 hours if not eating 2
- Target pre-meal glucose levels <140 mg/dL and random glucose levels <180 mg/dL 2
- Adjust insulin doses based on pattern recognition:
- High fasting glucose → increase basal insulin
- High pre-meal glucose → adjust previous meal's prandial insulin 2
Common Pitfalls to Avoid
Relying solely on sliding scale insulin - This approach is strongly discouraged as it treats hyperglycemia after it occurs rather than preventing it 1, 2
Inadequate total insulin dose - Failure to provide sufficient insulin will result in persistent hyperglycemia 2
Improper transition from IV to subcutaneous insulin - Failure to overlap administration can lead to rebound hyperglycemia 1
Insufficient monitoring - Glucose levels should be checked frequently during periods of instability 1
Not adjusting both basal and bolus components - Both components need regular titration based on glucose patterns 2
By following this systematic approach to managing severe hyperglycemia, you can effectively lower blood glucose levels from 400 mg/dL to target range, reducing the risk of complications associated with persistent hyperglycemia.